Sonobactericide: An Emerging Treatment Strategy for Bacterial Infections
Ultrasound has been developed as both a diagnostic tool and a potent promoter of beneficial bio-effects for the treatment of chronic bacterial infections. Bacterial infections, especially those involving biofilm on implants, indwelling catheters and heart valves, affect millions of people each year, and many deaths occur as a consequence. Exposure of microbubbles or droplets to ultrasound can directly affect bacteria and enhance the efficacy of antibiotics or other therapeutics, which we have termed sonobactericide. This review summarizes investigations that have provided evidence for ultrasound-activated microbubble or droplet treatment of bacteria and biofilm. In particular, we review the types of bacteria and therapeutics used for treatment and the in vitro and pre-clinical experimental setups employed in sonobactericide research. Mechanisms for ultrasound enhancement of sonobactericide, with a special emphasis on acoustic cavitation and radiation force, are reviewed, and the potential for clinical translation is discussed.
|Keywords||Antibiotic, Bacteria, Biofilm, Contrast agents, Infection, Microbubbles, Nanodroplet, Sonobactericide, Ultrasound|
|Persistent URL||dx.doi.org/10.1016/j.ultrasmedbio.2019.09.011, hdl.handle.net/1765/121930|
|Journal||Ultrasound in Medicine & Biology|
Lattwein, K.R, Shekhar, H. (Himanshu), Kouijzer, J.J.P. (Joop J.P.), van Wamel, W.J.B, Holland, C.K, & Kooiman, K. (2019). Sonobactericide: An Emerging Treatment Strategy for Bacterial Infections. Ultrasound in Medicine & Biology. doi:10.1016/j.ultrasmedbio.2019.09.011